Valuation Neurocrine Biosciences, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 11:37:15 09/03/2026 pm IST			5-day change	1st Jan Change
127.44 ^USD	-0.54%		-3.97%	-10.36%

07:35pm	Neurocrine Biosciences, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-09-2026 08:40 AM
04/03	Neurocrine Biosciences, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 11:50 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	8,080	11,482	12,946	13,820	14,141	12,860	-	-
Change	-	42.11%	12.74%	6.76%	2.32%	-9.06%	-	-
Enterprise Value (EV) ¹	7,704	10,363	11,397	12,005	11,598	9,880	9,134	7,107
Change	-	34.52%	9.97%	5.33%	-3.39%	-14.81%	-7.55%	-22.19%
P/E ratio	92.6x	76.6x	53.3x	41.5x	30.4x	21.6x	16.2x	12.7x
PBR	5.86x	6.75x	5.83x	5.24x	4.36x	3.17x	2.61x	2.12x
PEG	-	1.1x	0.9x	1.3x	0.7x	0.8x	0.5x	0.5x
Capitalization / Revenue	7.13x	7.71x	6.86x	5.87x	4.94x	3.73x	3.39x	3.09x
EV / Revenue	6.8x	6.96x	6.04x	5.1x	4.05x	2.87x	2.41x	1.71x
EV / EBITDA	58.9x	39.2x	42.4x	20.1x	17.9x	13.4x	9.59x	5.87x
EV / EBIT	75.2x	41.6x	45.4x	21x	18.7x	13.4x	9.31x	5.53x
EV / FCF	33x	32.1x	31.5x	21.5x	15.5x	12.3x	9.43x	6.43x
FCF Yield	3.03%	3.12%	3.17%	4.64%	6.46%	8.1%	10.6%	15.6%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.92	1.56	2.47	3.29	4.67	5.929	7.891	10.12
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,134	1,489	1,887	2,355	2,860	3,445	3,797	4,162
EBITDA ¹	130.7	264.1	268.7	597.6	649.2	734.9	952.6	1,212
EBIT ¹	102.5	249	250.9	570.5	619.1	738.4	981.2	1,285
Net income ¹	89.6	154.5	249.7	341.3	478.6	614.5	802.5	1,055
Net Debt ¹	-376.2	-1,119	-1,549	-1,816	-2,543	-2,979	-3,725	-5,752
Reference price ²	85.17	119.44	131.76	136.50	141.83	128.13	128.13	128.13
Nbr of stocks (in thousands)	94,867	96,134	98,252	1,01,247	99,706	1,00,363	-	-
Announcement Date	11/02/22	06/02/23	07/02/24	06/02/25	11/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NEUROCRINE BIOSCIENCES, INC.	21.61x	2.87x	13.44x	-.--%	1.29TCr
ELI LILLY AND COMPANY	29.11x	10.96x	22.02x	0.67%	88TCr
JOHNSON & JOHNSON	25.51x	5.94x	16.17x	2.2%	58TCr
ABBVIE INC.	24.99x	6.83x	13.71x	3.01%	41TCr
ROCHE HOLDING AG	18.38x	4.48x	11.08x	2.95%	35TCr
NOVARTIS AG	21.57x	5.8x	14.34x	2.79%	30TCr
ASTRAZENECA PLC	24.42x	5.09x	14.1x	1.71%	30TCr
MERCK & CO., INC.	27.07x	4.75x	14.84x	2.92%	29TCr
AMGEN INC.	24.86x	6.31x	11.22x	2.72%	20TCr
GILEAD SCIENCES, INC.	19.95x	6.07x	10.98x	2.26%	18TCr
Average	23.75x	5.91x	14.19x	2.12%	35.02TCr
Weighted average by Cap.	25.00x	7.00x	15.85x	2.07%